USE OF TOCILIZUMAB AND MESENCHYMAL STROMAL CELLS IN THE TREATMENT OF SEVERE COVID-19 - A CASE REPORT

BACKGROUND: Currently, there is no specific treatment for coronavirus disease, and some drugs and cell-based therapy have been tested as alternatives. This work aims to evaluate the effects of the combined use of humanized recombinant monoclonal antibody capable of binding the IL-6 receptor (Tociliz...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cytotherapy
Prif Awduron: Senegaglia, AC, Rebelatto, CLK, Franck, CL, Lima, JS, Daga, DR, Shigunov, P, Azambuja, AP, Bana, EG, Marsaro, DB, Schaidt, B, Micosky, A, Jamur, VR, Vaz, IM, Schluga, Y, Leite, LMB, Ribeiro, LL, Correa, A, Brofman, PRS
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Published by Elsevier Inc. 2021
Pynciau:
104
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8079859/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2021.02.111
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg